Sanofi To Probe Cancer Link With Insulin Use
Reuters:
Sanofi Aventis on Tuesday launched a research plan to probe the safety of insulin, including its Lantus diabetis drug.
(read the article>)
Reuters:
Sanofi Aventis on Tuesday launched a research plan to probe the safety of insulin, including its Lantus diabetis drug.
(read the article>)